The genomics personalized health market is experiencing rapid expansion, fueled by the growing emphasis on precision medicine and early disease detection. Valued at US$ 9.1 Bn in 2023, the market is projected to reach US$ 33.0 Bn by 2034, advancing at a remarkable CAGR of 12.2% during the forecast period. This growth reflects the increasing adoption of genomic technologies to deliver tailored...